Stockscreener 앱 받기
1.69
1.17%
-0.02
시간 외 거래:
1.69
전일 마감가:
$1.71
열려 있는:
$1.72
하루 거래량:
191.74K
Relative Volume:
0.31
시가총액:
$52.73M
수익:
$1.05M
순이익/손실:
$-48.82M
주가수익비율:
-0.9235
EPS:
-1.83
순현금흐름:
$-47.49M
1주 성능:
+6.96%
1개월 성능:
+12.67%
6개월 성능:
+38.52%
1년 성능:
-80.16%
1일 변동 폭
$1.63
$1.73
1주일 범위
$1.51
$1.73
52주 변동 폭
$1.06
$8.64
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
ATNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.69 | 49.29M | 1.05M | -48.82M | -47.49M | -1.83 |
|
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World
Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire
2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress
ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus
ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar
Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.
Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) Shareholders of Class Action Lawsuit and May 27, 2025 Deadline - ACCESS Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider
ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium LawsuitATNM - The Malaysian Reserve
ATNM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire
Shareholders that lost money on Actinium Pharmaceuticals, Inc. (ATNM) Urged to Join Class ... - Bluefield Daily Telegraph
Shareholders that lost money on Actinium Pharmaceuticals, - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - marketscreener.com
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Investor Alert: Deadline in Lawsuit on May 26, 2025 - openPR.com
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in Actinium Pharmaceuticals, Inc. (ATNM): Protect Your RightsContact Levi & Korsinsky Before May 27, 2025 - ACCESS Newswire
ATNM INVESTOR ALERT: Kirby McInerney LLP Reminds Actinium Pharmaceuticals, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit - Louisiana First News
Contact The Gross Law Firm by May 27, 2025 Deadline to Join Class Action Against Actinium Pharmaceuticals, Inc. (ATNM) - The Malaysian Reserve
ATNM Lawsuit Alert! Class Action Lawsuit Against Actinium Pharmaceuticals - TipRanks
Investors in Actinium Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - marketscreener.com
ATNM INVESTOR ALERT: Kirby McInerney LLP Reminds Actinium - GlobeNewswire
Investor Alert: Deadline Approaching to Join Actinium Pharmaceuticals, Inc. (ATNM) Class ActionContact Levi & Korsinsky - Louisiana First News
ROSEN, A TOP RANKED LAW FIRM, Encourages Actinium - GlobeNewswire
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a ... - Bluefield Daily Telegraph
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium - GlobeNewswire
Dimensional Fund Advisors LP Cuts Stock Position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Head-To-Head Survey: Xenetic Biosciences (NASDAQ:XBIO) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Did You Lose Money on Actinium Pharmaceuticals, Inc. (ATNM)? Levi & Korsinsky Urges Investors to Act Before May 27, 2025 - ACCESS Newswire
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar
Investors who lost money on Actinium Pharmaceuticals, - GlobeNewswire
Actinium Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - WV News
HC Wainwright Has Pessimistic Outlook of ATNM Q2 Earnings - Defense World
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Actinium Pharmaceuticals, Inc. (ATNM) - ACCESS Newswire
Actinium Faces Derivative Suit Over FDA Application Claims - Law360
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
1.24%
자본화:
|
볼륨(24시간):